Kindbody Stock $21.92

Forge Price BeaconForge Price 1 updated December 3, 2024

www.kindbody.comHealthcare / Healthcare providers & servicesFounded: 2018Funding to Date: $934.23MM

Kindbody is a health and tech company intended to offer fertility services and treatments for the modern woman. Founded in 2018 by Gina Bartasi and Joanne Schneider, KindBody is headquartered in New York, New York. Kindbody focuses on women's health, fertility, family-building and wellness benefits at the forefront.

Register To Buy and Sell Private Company Shares

For more details on private stock price information, financing and valuation for Kindbody, register or login.
Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Kindbody Stock Price

3M
6M
1Y
MAX
Forge Price 1
Date
12/03/2024
Price per Share
$21.92
Last Closed Trade 2
Close Date
xx/xx/xx
Last Closed Trade Price
$xx.xx
Last Funding Round (LFR)
Date
xx/xx/xx
Price per Share
$xx.xx

Kindbody Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
05/01/2023 Series D $30MM $xx.xx $1.81B Morgan Health, Perceptive Investors
Price per Share
$xx.xx
Shares Outstanding
582,329
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Morgan Health, Perceptive Investors
08/19/2022 Series C-3 $79.71MM $xx.xx $1.85B What If Ventures
Price per Share
$xx.xx
Shares Outstanding
1,547,230
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
What If Ventures
02/08/2022 Series C-2 $30MM $xx.xx $1.19B What If Ventures
Price per Share
$xx.xx
Shares Outstanding
834,725
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
What If Ventures
02/01/2022 Series C-1 $75MM $xx.xx $1.19B Undisclosed Investors
Price per Share
$xx.xx
Shares Outstanding
2,086,811
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
06/25/2021 Series C $61.89MM $xx.xx $670.48MM Bramalea Partners, Claritas Health Ventures, Eldridge, Gv, Monashee Investment Management, Perceptive Advisors, Rock Springs Capital, Rre Ventures
Price per Share
$xx.xx
Shares Outstanding
2,815,304
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bramalea Partners, Claritas Health Ventures, Eldridge, Gv, Monashee Investment Management, Perceptive Advisors, Rock Springs Capital, Rre Ventures
07/08/2020 Series B $32MM $xx.xx $181.18MM Claritas Health Ventures, Freemark Capital, Goodgrower, Gv, Nfp Ventures, Perceptive Advisors, Rock Springs Capital, Rre Ventures
Price per Share
$xx.xx
Shares Outstanding
5,449,590
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Claritas Health Ventures, Freemark Capital, Goodgrower, Gv, Nfp Ventures, Perceptive Advisors, Rock Springs Capital, Rre Ventures
04/17/2019 Series A $22.47MM $xx.xx $127.98MM Green D Ventures, Perceptive Advisors, Rre Ventures, Trail Mix Ventures, Winklevoss Capital
Price per Share
$xx.xx
Shares Outstanding
4,273,488
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Green D Ventures, Perceptive Advisors, Rre Ventures, Trail Mix Ventures, Winklevoss Capital
01/01/2019 Series Seed $575,000.00 $xx.xx $56.23MM Chelsea Clinton, Halle Tecco, Leandra Medine, Marc Mezvinsky, Marco Demeireles, Nat Turner, Tq Ventures, Vivek Garipalli
Price per Share
$xx.xx
Shares Outstanding
287,500
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Chelsea Clinton, Halle Tecco, Leandra Medine, Marc Mezvinsky, Marco Demeireles, Nat Turner, Tq Ventures, Vivek Garipalli
01/01/2019 Series Seed-2 $4.2MM $xx.xx $56.23MM Chelsea Clinton, Halle Tecco, Leandra Medine, Marc Mezvinsky, Marco Demeireles, Nat Turner, Tq Ventures, Vivek Garipalli
Price per Share
$xx.xx
Shares Outstanding
1,543,153
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Chelsea Clinton, Halle Tecco, Leandra Medine, Marc Mezvinsky, Marco Demeireles, Nat Turner, Tq Ventures, Vivek Garipalli
06/30/2018 Series Founder Convertible $1.56MM $xx.xx $7.8MM Annbeth Eschbach, Gina Bartasi
Price per Share
$xx.xx
Shares Outstanding
8,500,000
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Annbeth Eschbach, Gina Bartasi

Kindbody Investors Also Invested in These Private Companies

Leadership & Board

Leadership

Gina Bartasi
Co-Founder & Co-Chief Executive Officer
Angeline Beltsos MD
Co-Chief Executive Officer
Annbeth Eschbach
Co-Chief Executive Officer
Gregory Poulos
President
Richard Forsythe
Chief Technology Officer
Shilpa Patel JD
Chief Business & Legal Officer
Dean Morbeck Ph.D
Chief Scientific Officer
Fahimeh Sasan
Co-Founder, Chief Innovation Officer & Physician
Cindy Gentry
Chief Commercial & Strategic Advisor
Lynn Westphal
Chief Medical Officer

Kindbody stock FAQs

plusminus

Can you buy Kindbody stock?

As Kindbody is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private companies like Kindbody, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not accredited, find out how to begin the process and qualify for new investment opportunities.
plusminus

How to buy Kindbody stock?

To invest in a private company like Kindbody through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

  1. Create a free account to access Forge’s marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
plusminus

Can you sell Kindbody stock?

Yes, you may sell the Kindbody stock you currently own. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company’s interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
plusminus

How to sell Kindbody stock?

If you hold private company shares of Kindbody – whether as an employee or an early investor – Forge can help you sell them.

  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your Kindbody on our platform.
  3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.
plusminus

Is Kindbody a public company?

No, Kindbody is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
plusminus

What is Kindbody’s stock price?

Kindbody is a private company, meaning it does’t have a publicly traded stock price. However, as of 12/03/2024 the Kindbody Forge Price is $21.92 per share. The Forge Price is a derived price calculated for private companies like Kindbody to provide insights into their current valuation. Learn more about Forge Price.
plusminus

What is Kindbody’s stock ticker symbol?

Kindbody does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Kindbody News and Media Highlights

A fertility clinic failure destroyed my chance at motherhood

A recent investigation revealed issues at fertility clinic operator Kindbody related to embryo storage and handling. This follows past incidents at other clinics that resulted in loss of frozen eggs and embryos. The fertility industry remains lucrative despite ongoing quality control problems in specimen storage that have led to lawsuits.

Kindbody Continues Nationwide Expansion; Adds to Executive Leadership Team to Support Next Stage of Growth

Kindbody, a leading fertility clinic network and family-building benefits provider, expanded its executive team by appointing six new executives to support the company's growth as it opens four new clinics in 2024. The new hires bring expertise in healthcare, revenue growth, operations, compliance, science, and accounting.

Fertility Startup With a ‘Profit Mindset’ Pushes Doctors for More Egg Retrievals

The article discusses Bloomberg detecting unusual activity from a computer network and requiring confirmation that the user is not a robot before allowing continued access. The article then provides information on troubleshooting and contacting support if issues persist.

Kindbody Receives $25M from Morgan Health to Scale Family-building Care

Kindbody, a company for fertility and family-building care, announced Monday that it secured a $25 million investment from Morgan Health to expand its business and services.
Browse Insights
Updated on: Dec 3, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge.  Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

2. The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.